MPN Advances Day
2019 E-Learning

Keep up-to-date with the latest advances in MPNs!

The Myeloproliferative Neoplasms (MPN) Advances Day 2019 took place on 15 November, in London, UK. Leading experts came together to present recent advances in understanding the disease biology of MPNs and how they can be treated, providing an opportunity for clinicians to keep abreast of the field.

Key topics from the meeting included essential thrombocythemia (ET), polycythemia vera, myelofibrosis, and atypical MPNs. Presentation topics included clonal hemopoiesis to leukemia, novel therapies for mastocytosis, and what new therapies can offer MPN patients.
View e-learning webcasts from all three sessions below.

Session 1

Featured Presentation:

From Clonal Haemopoiesis
to Leukemia

Adam Mead

New Insights into the Management of ET
Anna Godfrey
BSH Guidelines for Non-Clonal Erythrocytosis
Mary Frances McMullin
Current and Future Therapies for Polycythemia Vera
Jean-Jacques Kiladjian

Session 2

Featured Presentation:

Systemic Mastocytosis: New Treatments

Mark Drummond

Atypical MPNs: Focus on CNL and 8p11 Disease
Andreas Reiter
Cardiology Updates for Hematologists
Arjun Ghosh

Session 3

Featured Presentation:

What can New Therapies Offer MPN Patients?

Claire Harrison

The Challenges of AML Following MPNs
Steve Knapper
Medical Management of Myelofibrosis
Ruben Mesa

Related Content on VJHemOnc